Navigation path

Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

Human monoclonal IgG1 antibody against tissue factor pathway inhibitor

EU orphan designation number: EU/3/16/1752   
Active ingredient: Human monoclonal IgG1 antibody against tissue factor pathway inhibitor
Indication: Treatment of haemophilia A
Sponsor: Pfizer Europe MA EEIG
Boulevard de la Plaine 17, 1050 Bruxelles, Belgique/ Pleinlaan 17, 1050 Brussel, België

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
18/10/2016 Orphan designation EMA/OD/093/16 (2016)6742 of 14/10/2016
21/11/2018 Transfer of orphan designation EMA/OD/093/16/T/01 (2018)7838 of 19/11/2018